Past News

2007

Appointment of Vice President, Business Development

September 10, 2007

Chris Wagner joins Sirius Genomics as Vice President, Business Development. Mr. Wagner brings 15 years of collective experience in marketing, sales and business development to Sirius. Celia Courchene will now focus on internal development taking the role of Vice President, Corporate Affairs.

Appointment of Vice President, Intellectual Property

August 13, 2007

Jennifer Kaufman-Shaw joins Sirius Genomics as the new Vice President, Intellectual Property. Dr. Kaufman-Shaw brings her expertise as scientific patent counsel with over 15 years of legal experience to Sirius.

New Website Launched

March 22, 2007

Sirius Genomics launched new website and logo.

2006

Appointment of Vice President, Business Development

October 1, 2006

Celia Courchene joined Sirius as the new Vice President, Business Development. Ms Courchene brings 20 years of experience and expertise in business development and business law to the Company.

Appointment of Vice President, Research

August 16, 2006

Asim Siddiqui joins Sirius as the new Vice President, Research. Dr. Siddiqui is an expert in genomics and brings 12 years of experience with him to Sirius.

Closing of Series A Financing

June 23, 2006

Sirius Genomics closed it Series A Financing raising $6.3 million.

Signing of Sirius-Tm Bioscience Agreement

March 17, 2006

Sirius Genomics and Tm Bioscience sign a development and license agreement to jointly collaborate on the development and commercialization of diagnostic kits to identify patients who will respond to current available treatments for sepsis.

Appointment of new CEO

February 1, 2006

Sirius Genomics is pleased to announce the recent appointment of Dr. Brad Popovich as President and CEO. Dr. Popovich joined the company last year as Chief Operating Officer. Dr. James Russell, former President and CEO, has been appointed as Chief Medical Officer in order to refocus his scientific expertise to expand the research, discovery and development side of the company.